Trimetazidine Teva

Medicinal product

(Invented) name

Trimetazidine Teva

Active substance (s)

Trimetazidino dihidrochloridas

Strength

35 mg

Pharmaceutical form

pailginto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C01EB15, Trimetazidine

Marketing authorisation holder

Teva Pharma B.V., Nyderlandai

Date of authorisation

2011-02-19

Date of renewal

2020-11-25

Documents

2345 Trimetazidine Teva PCS PL 2025 01 08.docx

2345 Pakuotės lapelis 2025 01 08.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

HU/H/0344/001

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Trimetazidino dihidrochloridas	35 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
22574	25337	1025337	lizdinė plokštelė	N20		Receptinis	LT/1/10/2345/001	Netiekiama	-	-	No	-	-
22575	25338	1025338	lizdinė plokštelė	N60		Receptinis	LT/1/10/2345/002	Tiekiama	-	-	No	-	-	Download
22576	25339	1025339	lizdinė plokštelė	N120		Receptinis	LT/1/10/2345/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2020-11-25	Perregistruotas
2011-02-19	Registruotas